MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Infectious Disease_Hepatitis
Three Rivers Pharmaceuticals
Parents
*Architects: Infectious Disease_Hepatitis
*Industry: Pennsylvania
Companies: Acquired_(M&A)
Finance & Acquisitions: Kadmon
Children
2010: Kadmon Pharmaceuticals Acquires Three Rivers Pharmaceuticals, LLC For More Than $100 Million (2010)
The company also markets AMPHOTEC® (Amphotericin B Cholesteryl Sulfate) for the treatment of invasive aspergillosis, a life-thre
Three Rivers currently markets several products for the growing hepatitis C market, including INFERGEN™ (Consensus Interferon),
Three Rivers is also developing a suite of generic products in the area of oncology. Kadmon expects to maintain the company's Wa
Three Rivers Pharmaceuticals CEO Donald Kerrish
Warrendale, Pennsylvania